These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31718676)

  • 1. The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS.
    Wells JM; Xing D; Viera L; Burkes RM; Wu Y; Bhatt SP; Dransfield MT; Couper DJ; O'Neal W; Hoffman EA; Gaggar A; Barjaktarevic I; Curtis JL; Labaki WW; Han MLK; Freeman CM; Putcha N; Schlange T; Blalock JE;
    Respir Res; 2019 Nov; 20(1):254. PubMed ID: 31718676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Placebo-controlled Trial of Roflumilast. Effect on Proline-Glycine-Proline and Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.
    Wells JM; Jackson PL; Viera L; Bhatt SP; Gautney J; Handley G; King RW; Xu X; Gaggar A; Bailey WC; Dransfield MT; Blalock JE
    Am J Respir Crit Care Med; 2015 Oct; 192(8):934-42. PubMed ID: 26151090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Radicioni G; Ceppe A; Ford AA; Alexis NE; Barr RG; Bleecker ER; Christenson SA; Cooper CB; Han MK; Hansel NN; Hastie AT; Hoffman EA; Kanner RE; Martinez FJ; Ozkan E; Paine R; Woodruff PG; O'Neal WK; Boucher RC; Kesimer M
    Lancet Respir Med; 2021 Nov; 9(11):1241-1254. PubMed ID: 34058148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LC-MS/MS method for proline-glycine-proline and acetylated proline-glycine-proline in human plasma.
    Tiwary E; Berryhill TF; Wilson L; Barnes S; Prasain JK; Wells JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123815. PubMed ID: 37453387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of FEV
    Yee N; Markovic D; Buhr RG; Fortis S; Arjomandi M; Couper D; Anderson WH; Paine R; Woodruff PG; Han MK; Martinez FJ; Barr RG; Wells JM; Ortega VE; Hoffman EA; Kim V; Drummond MB; Bowler RP; Curtis JL; Cooper CB; Tashkin DP; Barjaktarevic IZ
    Chest; 2022 Apr; 161(4):949-959. PubMed ID: 34767825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
    Wells JM; Parker MM; Oster RA; Bowler RP; Dransfield MT; Bhatt SP; Cho MH; Kim V; Curtis JL; Martinez FJ; Paine R; O'Neal W; Labaki WW; Kaner RJ; Barjaktarevic I; Han MK; Silverman EK; Crapo JD; Barr RG; Woodruff P; Castaldi PJ; Gaggar A;
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An aberrant leukotriene A4 hydrolase-proline-glycine-proline pathway in the pathogenesis of chronic obstructive pulmonary disease.
    Wells JM; O'Reilly PJ; Szul T; Sullivan DI; Handley G; Garrett C; McNicholas CM; Roda MA; Miller BE; Tal-Singer R; Gaggar A; Rennard SI; Jackson PL; Blalock JE
    Am J Respir Crit Care Med; 2014 Jul; 190(1):51-61. PubMed ID: 24874071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort.
    Bhatt SP; Nath HP; Kim YI; Ramachandran R; Watts JR; Terry NLJ; Sonavane S; Deshmane SP; Woodruff PG; Oelsner EC; Bodduluri S; Han MK; Labaki WW; Michael Wells J; Martinez FJ; Barr RG; Dransfield MT;
    Respir Res; 2018 Dec; 19(1):257. PubMed ID: 30563576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
    Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
    Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme defines matrikine-regulated inflammation and fibrosis.
    O'Reilly PJ; Ding Q; Akthar S; Cai G; Genschmer KR; Patel DF; Jackson PL; Viera L; Roda M; Locy ML; Bernstein EA; Lloyd CM; Bernstein KE; Snelgrove RJ; Blalock JE
    JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokers.
    Singh D; Fox SM; Tal-Singer R; Plumb J; Bates S; Broad P; Riley JH; Celli B;
    Thorax; 2011 Jun; 66(6):489-95. PubMed ID: 21441172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
    Zhang WZ; Hoffman KL; Schiffer KT; Oromendia C; Rice MC; Barjaktarevic I; Peters SP; Putcha N; Bowler RP; Wells JM; Couper DJ; Labaki WW; Curtis JL; Han MK; Paine R; Woodruff PG; Criner GJ; Hansel NN; Diaz I; Ballman KV; Nakahira K; Choi ME; Martinez FJ; Choi AMK; Cloonan SM
    Respir Res; 2021 Apr; 22(1):126. PubMed ID: 33902556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
    Esther CR; O'Neal WK; Anderson WH; Kesimer M; Ceppe A; Doerschuk CM; Alexis NE; Hastie AT; Barr RG; Bowler RP; Wells JM; Oelsner EC; Comellas AP; Tesfaigzi Y; Kim V; Paulin LM; Cooper CB; Han MK; Huang YJ; Labaki WW; Curtis JL; Boucher RC;
    Chest; 2022 May; 161(5):1239-1249. PubMed ID: 34801592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS).
    Freeman CM; Crudgington S; Stolberg VR; Brown JP; Sonstein J; Alexis NE; Doerschuk CM; Basta PV; Carretta EE; Couper DJ; Hastie AT; Kaner RJ; O'Neal WK; Paine R; Rennard SI; Shimbo D; Woodruff PG; Zeidler M; Curtis JL
    J Transl Med; 2015 Jan; 13():19. PubMed ID: 25622723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study.
    Singh D; Edwards L; Tal-Singer R; Rennard S
    Respir Res; 2010 Jun; 11(1):77. PubMed ID: 20550701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of blood cytokines and chemokines in assessing COPD.
    Bradford E; Jacobson S; Varasteh J; Comellas AP; Woodruff P; O'Neal W; DeMeo DL; Li X; Kim V; Cho M; Castaldi PJ; Hersh C; Silverman EK; Crapo JD; Kechris K; Bowler RP
    Respir Res; 2017 Oct; 18(1):180. PubMed ID: 29065892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease.
    Bhatt SP; Soler X; Wang X; Murray S; Anzueto AR; Beaty TH; Boriek AM; Casaburi R; Criner GJ; Diaz AA; Dransfield MT; Curran-Everett D; Galbán CJ; Hoffman EA; Hogg JC; Kazerooni EA; Kim V; Kinney GL; Lagstein A; Lynch DA; Make BJ; Martinez FJ; Ramsdell JW; Reddy R; Ross BD; Rossiter HB; Steiner RM; Strand MJ; van Beek EJ; Wan ES; Washko GR; Wells JM; Wendt CH; Wise RA; Silverman EK; Crapo JD; Bowler RP; Han MK;
    Am J Respir Crit Care Med; 2016 Jul; 194(2):178-84. PubMed ID: 26808615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.